Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

3 clinical studies listed.

Filters:

Diabetic Retinopathy, DR

Tundra lists 3 Diabetic Retinopathy, DR clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

COMPLETED

NCT07850245

The Effect of Different Auditory Types on Visual Evoked Potentials (VEP)

To investigate the effect of different sound types on pattern visual evoked potential (VEP) responses among healthy adults

Gender: All

Ages: 20 Years - 60 Years

Updated: 2026-09-30

1 state

Healthy Adult
Diabetic Retinopathy, DR
ENROLLING BY INVITATION

NCT05296447

Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With and Without Diabetic Retinopathy

This is a prospective study designed to evaluate the long-term safety and efficacy of ABBV-RGX-314. Eligible participants are those who were previously enrolled in a clinical study of DR with and without center involved-diabetic macular edema (CI-DME) in which they received suprachoroidal space (SCS) administration of ABBV-RGX-314. Enrollment of each participant in the current study should occur after the participant has completed either the end of study or early discontinuation visit in the previous (parent) clinical study. Participants will be followed for a total of 5 years post-ABBV-RGX-314 administration (inclusive of the parent study). As such, the total study duration for each participant may vary depending on when they enroll in the current study following ABBV-RGX-314 administration in the parent study.

Gender: All

Updated: 2026-08-05

13 states

Diabetic Retinopathy, DR
COMPLETED

NCT07526857

Epivascular Glia Regression and Macular Pigment Restoration After Faricimab in Diabetic Retinopathy

The aim of the study is to evaluate in diabetic patients affected by diabetic retinopathy epivascular glia regression and macular pigment restoration after faricimab injection in diabetic retinopathy in a 1 year follow up

Gender: All

Updated: 2026-04-13

1 state

Diabetic Retinopathy, DR